Biologics Treatment Selection in Patients With Moderate-to-Severe Asthma

home / around-the-practice / biologics-treatment-selection-in-patients-with-moderate-to-severe-asthma

A panel of experts discuss the role of type 2 inflammation in asthma, challenges with long-term use of corticosteroids, and the emerging role of biologics and various mechanisms of actions in the management of asthma.

© 2024 MJH Life Sciences

All rights reserved.